Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

Credit: Getty Images Researchers developed a guide for clinicians to use ozanimod for the treatment of moderate to severe ulcerative colitis. Ulcerative colitis (UC) is a chronic and relapsing type of ...

Key Takeaways Oral small-molecule therapies are redefining first-line treatment in moderate to severe ulcerative colitis (UC) by offering noninfusion alternatives with rapid onset and high efficacy.

Omvoh achieved primary and key secondary endpoints, including sustained clinical remission in pivotal trials Omvoh delivered significant improvement in bowel urgency, reported by people with UC as one ...

Ulcerative colitis (UC) can be described in many ways through a variety of symptoms, but only those who live with it every day know how detrimental it can truly be. At first, the pain was terrifying.

Maxim Group analyst Naz Rahman maintained a Buy rating on Palisade Bio (PALI – Research Report) yesterday and set a price target of $22.50. Naz Rahman has given his Buy rating due to a combination of ...

What Is Proctitis and How Does It Compare to UC? Proctitis is inflammation of the rectum, the last part of the large intestine that connects the colon to the anus. Ulcerative colitis (UC) is a type of ...

INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 ...